Slavica Lazarević, Maja Đanić, Nebojša Pavlović. Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment. // BioDrugs. – 2025. – DOI: 10.1007/s40259-025-00739-9. – URL: https://doi.org/10.1007/s40259-025-00739-9
Slavica Lazarević, Maja Đanić, & Nebojša Pavlović (2025). Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment. BioDrugs. https://doi.org/10.1007/s40259-025-00739-9
Slavica Lazarević, et al. “Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment.” BioDrugs, 2025. doi:10.1007/s40259-025-00739-9.
@article{Lazarevi2025,
title = {Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment},
author = {Lazarević, Slavica and Đanić, Maja and Pavlović, Nebojša},
journal = {BioDrugs},
year = {2025},
doi = {10.1007/s40259-025-00739-9},
url = {https://doi.org/10.1007/s40259-025-00739-9}
}